Proinflammatory and anti-inflammatory cytokine changes related to menopause

Przeglad Menopauzalny

Volumn 13, Issue 3, 2014, Pages 162-168

  Malutan, Andrei Mihai ^a   Dan, Mihu ^a   Nicolae, Costin ^a   Carmen, Mihu ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Cytokine; Inflammation; Interleukin; Menopause; Sex hormones

Indexed keywords

CYTOKINE; ESTRADIOL; FOLLITROPIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LUTEINIZING HORMONE; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLIMACTERIUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE FERTILITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MENOPAUSE; PREMENOPAUSE; PROTEIN BLOOD LEVEL; SURGICAL MENOPAUSE;

EID: 84924732149     PISSN: 16438876     EISSN: 22990038     Source Type: Journal    
DOI: 10.5114/pm.2014.43818     Document Type: Article

References (30)

1. Su HI, Freeman EW. Hormone changes associated with the menopausal transition. Minerva Ginecol 2009; 61: 483-489.
2. Cioffi M, Esposito K, Vietri MT, et al. Cytokine pattern in postmenopause. Maturitas 2002; 41: 187-192.
3. Yasui T, Uemura H, Tomita J, et al. Association of interleukin-8 with hot flushes in premenopausal, perimenopausal and postmenopausal women and bilateral oophorectomized women. J Clin Endocrinol Metab 2006; 91: 4805-4808.
4. Ertek S, Cicero A. Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions. Arch Med Sci 2012; 8: 794-804.
5. Pino AM, Ríos S, Astudillo P, et al. Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women. J Bone Miner Res 2010; 25: 492-498.
6. Benedusi V, Meda C, Della Torre S, et al. A lack of ovarian function increases neuroinflammation in aged mice. Endocrinology 2012; 153: 2777-2788.
7. Wakkach A, Cottrez F, Groux H. Can interleukin-10 be used as a true immunoregulatory cytokine Eur Cytokine Netw 2000; 11: 153-160.
8. Gonzalez C, Cava F, Ayllon A, et al. Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals. Clin Chem Lab Med 2001; 39: 836-841.
9. Lang UE, Gallinat J, Danker-Hopfe H, et al. Nerve growth factor serum concentrations in healthy human volunteers: physiological variance and stability. Neurosci Lett 2003; 344: 13-16.
10. Swiatecka D, Markiewicz LH, Wroblewska B. Experimental immunology: Pea protein hydrolysate as a factor modulating the adhesion of bacteria to enterocytes, epithelial proliferation and cytokine secretion - an in vitro study. Centr Eur J Immunol 2012; 37: 227-231.
11. Ho GY, Xue XN, Burk RD, et al. Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women. Cytokine 2005; 30: 1-6.
12. Kaplan RC, Ho GY, Xue X, et al. Within-individual stability of obesityrelated biomarkers among women. Cancer Epidemiol Biomarkers Prev 2007; 16: 1291-1293.
13. Ciebiada M, Kasztalska K, Gorska-Ciebiada M, et al. Basic research: Expression of IL-7 receptor in human peripheral regulatory T cells. Arch Med Sci 2013; 9: 555-560.
14. Lee SA, Kallianpur A, Xiang YB, et al. Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 2007; 16: 2464-2470.
15. Gu Y, Zeleniuch-Jacquotte A, Linkov F, et al. Reproducibility of serum cytokines and growth factors. Cytokine 2009; 45: 44-49.
16. Wei M, Kuukasjärvi P, Laurikka J, et al. Relations of cytokines to vasodilatation after coronary artery bypass grafting. World J Surg 2003; 27: 1093-1098.
17. Slotwinska SM. Cytokines and periodontitis. Part I: interleukin-1 and interleukin-1 receptor antagonist. Centr Eur J Immunol 2012; 37: 173-177.
18. Chao TH, Yu HN, Huang CC, et al. Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women. Ann Saudi Med 2010; 30: 437-441.
19. Rusinska A, Chlebna-Sokol D. Evaluation of interleukin-1 and-6 in the etiopathogenesis of idiopathic osteoporosis and osteopenia in children. Arch Immunol Ther Exp 2005; 53: 257-265.
20. Moffett SP, Zmuda JM, Oakley JI, et al. Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. J Clin Endocrinol Metab 2005; 90: 3491-3497.
21. Hofmann SR, Rösen-Wolff A, Tsokos GC, et al. Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin Immunol 2012; 143: 116-127.
22. Chen WY, Cheng BC, Jiang MJ, et al. IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006; 26: 2090-2095.
23. Maiorino MI, Schisano B, Di Palo C, et al. Interleukin-20 circulating levels in obese women: effect of weight loss. Nutr Metab Cardiovasc Dis 2010; 20: 180-185.
24. Kim OY, Chae JS, Paik JK, et al. Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy non obese women. Age (Dordr) 2012; 34: 415-425.
25. Yasui T, Uemura H, Yamada M, et al. Associations of interleukin-6 with interleukin-1beta, interleukin-8 and macrophage inflammatory protein-1beta in midlife women. Cytokine 2008; 41: 302-306.
26. Akyol S, Cnar SA, Purisa S, et al. Relationship between lymphocytes, IL2 and the hormones E2, LH, PRG and FSH in menopausal and postmenopausal women. Am J Reprod Immunol 2011; 66: 304-309.
27. Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 2012; 139: 230-239.
28. Vural P, Canbaz M, Akgul C. Effects of menopause and postmenopausal tibolone treatment on plasma TNFalpha, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers. Pharmacol Res 2006; 53: 367-371.
29. Chiricozzi A, Guttman-Yassky E, Suárez-Fariñas M, et al. Integrative responses to IL-17 and TNF in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 2011; 131: 677-687.
30. Kawaguchi M, Kokubu F, Fujita J, et al. Role of interleukin-17F in asthma. Inflamm Allergy Drug Targets 2009; 8: 383-389.